Marco Robello
About Marco Robello
Marco Robello is a Postdoctoral Visiting Fellow at The National Institutes of Health, specializing in the design and synthesis of small molecules targeting HIV and cancer. He holds a PhD in Pharmaceutical Sciences from Università di Pisa and has experience in tutoring undergraduate students and conducting research in organic synthesis.
Work at National Institutes of Health
Marco Robello has been serving as a Postdoctoral Visiting Fellow at the National Institutes of Health (NIH) since 2017. His work focuses on the design and synthesis of small molecules that specifically target HIV and cancer. This role allows him to contribute to significant research initiatives aimed at developing therapeutic strategies for these diseases. He has been involved in various projects under the mentorship of experienced researchers, enhancing his expertise in pharmaceutical sciences.
Education and Expertise
Marco Robello studied at the Università di Pisa, where he earned a Doctor of Philosophy (PhD) in Pharmaceutical Sciences from 2014 to 2017. He also completed a Master of Science (M.Sc.) in Pharmaceutical Chemistry and Technology from 2007 to 2013. His educational journey began at Liceo Scientifico Lanfranconi, where he obtained a scientific diploma. His academic background equips him with a strong foundation in organic multi-step synthesis, purification, and characterization of small molecules.
Background
Marco Robello's academic and professional journey includes significant experiences in Italy and the United States. He worked at the University of Pisa for eight months on his Master Thesis Project from 2012 to 2013. He also served as a Visiting PhD Student at the National Institute of Mental Health (NIMH) in 2016 for six months. His roles have included tutoring undergraduate students during both his PhD and postdoctoral studies, reflecting his commitment to education and mentorship.
Achievements
During his postdoctoral fellowship, Marco Robello contributed to the design and synthesis of small molecules targeting HIV and cancer, showcasing his research capabilities. His work at the National Institutes of Health has allowed him to engage in impactful research projects. Additionally, he has gained experience in organic synthesis and has worked under the mentorship of Dr. Daniel H. Appella at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).